SEC Form 4 · accession 0001179110-15-009852
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole Onetto
Director
Period of report
Jun 15, 2015
Accepted (ET)
Jun 16, 2015 · 11:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2015 | M | 3,211 | $7.82 | A | 3,211 | D | |
| Common StockF2 | Jun 15, 2015 | S | 3,211 | $13.8571 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $7.82 | Jun 15, 2015 | M | 3,211 | D | Feb 1, 2011 | Nov 16, 2020 | Common Stock | 3,211 | 3,000 | D |
Explanation of responses
- F1Exercisable as to 1,553 shares commencing on February 1, 2011, 1,553 shares commencing on May 1, 2011, 1,552 shares commencing on August 1, 2011 and 1,553 shares commencing on November 1, 2011, contingent upon the individual remaining a director as of each vesting date.
- F2Weighted average price of shares sold